Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website

... drugs that were prescribed as part of the diet drug combination Fen Phen —were recalled in ... the Fen Phen recall was issued—the Food and drug Administration issued a warning about herbal Fen ... devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP or call toll-free ...

Duane Reade Holdings, Inc. Announces Expiration and Results of Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Consents to Related Indentures

... Founded in 1960, Duane Reade is the largest drug store chain in New York City, offering a wide ... in general, the competitive environment in the drug store industry in general and in the New York ... prescription reimbursement rates and prescription drug benefits, changes in federal and state laws and ...

Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015

... Founded in 1960, Duane Reade is the largest drug store chain in New York City, offering a wide ... in general, the competitive environment in the drug store industry in general and in the New York ... prescription reimbursement rates and prescription drug benefits, changes in federal and state laws and ...

Nuvo Announces 2009 second quarter financial results

... - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, today announced its ...

Price Chopper Supermarkets Deploy Micromedex Solutions From Thomson Reuters as Key Component of Its Patient-Centered Care Initiatives

... Micromedex (R) evidence-based solutions for drug and disease reference, patient education, and ... portal to provide customers with evidence-based drug information. The Consumer Health Solution provides pill images and covers adverse drug interactions, alternative medicines, and general ...

Labopharm Reports Results for Second Quarter Fiscal 2009

... "Following discussions with the U.S. Food and drug Administration regarding its complete response ... - Following discussions with the U.S. Food and drug Administration (FDA), Labopharm intends to submit ... letter from the FDA indicating that its new drug application (NDA) cannot be approved in its ...

Mother & Daughter Celebrate Victory Over 'Meth'

... family, active in their church with no history of drug or alcohol abuse in the family. . . until their ... and now happily married." Susan makes time for drug education and answers questions from parents of ... For more information about the Narconon drug rehabilitation program, visit ...

US Oncology Reports Second Quarter Operating Results

... and the associated pressures on reimbursement and drug margins. We expect that this trend toward ... management in this offering, as well as lower ESA drug volumes. Pharmaceutical services EBITDA was ... as well as payments made under a generic drug inventory management program in the second ...

Efforts by Blue Cross Blue Shield of Michigan, Physician Practices Help Michigan Become a Leading Adopter of E-prescribing

... To help prevent potentially dangerous drug interactions, a primary care physician can use an ... get alerts about potential harmful interactions, drug allergies and dosing issues. E-prescribing also ... accounts; Medicare Advantage; Part D Prescription drug plans, and MyBlue(SM) products in the ...

iPierian Appoints Dr. Chad Cowan and Dr. Konrad Hochedlinger to Scientific Advisory Board

... company focused on changing the paradigm of drug discovery and development through the application ... great potential for disease research, preclinical drug testing and cell-based therapy. iPierian's approach places the patient at the forefront of the drug discovery process in order to ...

Gold Standard/Elsevier Launches MedCounselor Consumer Drug Information Modules

... today the launch of three MedCounselor consumer drug information modules for pharmacies and health ... unknown tablets or capsules and checks for drug interactions. The modules are indispensable in helping to increase consumer compliance to their drug regimens and avoid costly and sometimes deadly ...

SXC Health solutions announces record second quarter financial results

... for the Commonwealth of Virginia's Medicaid drug rebate program - Subsequent to quarter-end, ... only on the basis of the administrative fee; drug ingredient cost is not included in revenues ... competition, the growth of prescription drug utilization rates at predicted levels, the ...

Lexi-Comp ONLINE™ for Oral Surgery

... comprehensive pharmacology information and fast drug interaction screening tools tailored to the needs ... the comprehensive pharmacology information and drug interaction screening required by clinicians ... features Lexi-Drugs®, Lexi-Comp's core drug database enhanced with dental-specific fields of ...

Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million

... a proposed $41.5 million settlement with drug manufacturers Merck & Co. (NYSE: MRK ) and ... Zetia and Zocor, a statin available as a generic drug for about one-third the cost. The Food and drug Administration (FDA) approved Zetia and Vytorin ...

While Some New Agents Will Achieve Strong Sales, the Migraine Drug Market Will Decline $1.3 Billion by 2018 as Generic Erosion Takes Toll on Top-Selling Brands

... losses to generic competitors, the migraine drug market will decline from $4.7 billion in 2008 to ... and Ortho-McNeil/Janssen-Cilag's anti-epileptic drug Topamax, used for migraine prophylaxis, will ... Jonathan Searles. "If the long-term safety of the drug is confirmed, telcagepant will offer a useful ...

Report: Microsoft Sponsoring Ads for Rogue Internet Pharmacies

... Also, the authors ordered another prescription drug from a Microsoft-sponsored advertisement that ... the product of organized crime and vast illicit drug networks, many of them based in Russia and ... Microsoft is facilitating prescription drug abuse and the proliferation of counterfeit drugs, ...

Cambrex Reports Second Quarter 2009 Results

... an API that incorporates the Company's polymeric drug delivery technology. Partially offsetting these ... in support of our controlled substances and drug delivery initiatives." Second Quarter ... including APIs, advanced intermediates, enhanced drug delivery, and other products for branded and ...

FDA extends review of Pennsaid(R) diclofenac sodium topical solution

... and Nuvo Research Inc. (TSX:NRI), a Canadian drug development company, today announced that the U.S. Food and drug Administration (FDA) has set a new action date under the Prescription drug User Fee Act (PDUFA) for Pennsaid (diclofenac ...

Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA

... in children and adolescents, the U.S. Food and drug Administration announced Tuesday. The drugs, ... cancer, White noted. "Then you are giving a drug that probably increases the risk as well. But are ... Crystal Rice, spokeswoman, U.S. Food and drug Administration; Patience White, M.D., chief ...

CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine

... International Announces FDA Reported Psychiatric drug Side Effects Search Engine: Decrypted FDA reports ... that have been reported to the U.S. Food and drug Administration (FDA) by doctors, pharmacists, ... to the public in an easy to search psychiatric drug side effects database and search engine. The ...

American Association of Oral and Maxillofacial Surgeons Says Only Trained Dental and Medical Practitioners Should Administer and Monitor Anesthesia

... ... Diprivan, or its generic name propofol, is a drug meant only for use in a medical setting by ... the provision of general anesthesia. Though the drug is often used for procedures requiring sedation, ... can have extremely variable responses to the drug and some patients can become completely ...

Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment

... announced today that the U.S. Food and drug Administration (FDA) has approved the trade name ... as degarelix and carries the same National drug Code (NDC). FIRMAGON is being reimbursed by all ... receptor antagonist approved by the U.S. Food and drug Administration (FDA) for the treatment of ...

Office of National Drug Control Policy Taps RIESTER creative for Use in National Anti-Meth Campaign

... has been selected by the Office of National drug Control Policy (ONDCP) to become a key resource ... action to help a loved one suspected of drug use and encouraged users to believe that recovery is possible. "We all know the ravages this drug can cause; however, this work from Utah shows ...

Data Conversion Laboratory Supports Newest SPL Requirements For Life Sciences Industry

... by the FDA community to facilitate communicating drug labeling data reliably among various medical ... 2010. Additionally, as a result of the Food and drug Administration Amendments Act of 2007 mandating ... registration, NDC labeler code requests and drug listing regulatory requirements. As one ...

Medicines Top Source of Kids' Poisonings

... especially in younger children, Budnitz believes drug manufacturers must create better child safety ... the CDC is working with over-the-counter drug manufacturers to encourage the implementation of ... Following concerns raised by the U.S. Food and drug Administration, ...

Arcadia HealthCare's DailyMed(TM) Signs Deal with Comfort Keepers(R), A Leading Provider of In-Home Care

... ( www.DailyMedRx.com ) is Arcadia's proprietary drug packaging system that combines patients' ... The DailyMed program improves patient care and drug utilization while reducing drug and hospitalization costs for private and ...

AlphaRx and Venturepharm Announce Collaboration Agreement

... biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations ... Group (the "Venturepharm") to establish a drug development center in China Medical City, ... as a platform for the development of innovative drug products for the fast growing China ...

West Announces Second Quarter 2009 Results

... Other product categories that improved were drug reconstitution systems, and seals for vials and ... by lower sales of components for lyophilized drug products and disposable medical devices. ... 6, 2009 the Company completed the purchase of the drug delivery device business assets of Plastef ...

Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth Conference

... commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating ... commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or ...

Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer

... trial of Bezielle (formerly BZL101), their lead drug candidate for advanced breast cancer. In the ... Bezielle to Phase 2 clinical testing as the drug continues to have an improved safety profile over ... who are eagerly awaiting an oral anticancer drug with minimal side effects that can extend life ...

Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis

... . LX2931 is an orally-delivered, small molecule drug candidate that has recently completed Phase 1 ... In addition to LX2931, Lexicon has two other drug candidates progressing in Phase 2 clinical ... for human disease. Lexicon currently has five drug candidates in development for autoimmune disease, ...

Consumer Reports Swine Flu Survival Kit Prepares Consumers for Potentially Tough Flu Season This Fall

... identifies the Consumer Reports Best Buy drug choices to treat eight common conditions, ... . By opting for Best Buy drug choices, consumers can realize significant ... for remedies: Brand-name extensions. drug manufacturers often use brand names to launch ...

DURECT Corporation Announces Second Quarter 2009 Financial

... injectable technologies to address specific drug delivery challenges for both small molecule and ... to resist common methods of prescription drug misuse and abuse. -- POSIDUR(TM) ... that our technologies can achieve the drug delivery objectives set forth by our ...

Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments

... towards activities that support filing a New drug Application, or NDA, for lorcaserin. Arena ... and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a ... receptors, an important class of validated drug targets, which includes compounds being evaluated ...

One in 10 High School Seniors Have Used Narcotic Painkillers

... of the potential for complications including drug interactions and dependence, tolerance and ... More information For more information on drug abuse, visit the U.S. National Institute on drug Abuse . SOURCES: Sean ...

New microchip technology performs 1,000 chemical reactions at once

... could accelerate the identification of potential drug candidates for treating diseases like cancer. ... a technique often used to identify potential drug molecules that bind tightly to protein enzymes to ... offering a new method to quickly screen which drug molecules may work most effectively with a ...

New Study Shows That Pharmacogenomics Could Benefit Patients, Spur Investment in Innovation

... study, "The Future Costs, Risks and Rewards of drug Development: The Economics of Pharmacogenomics," ... also could help to identify patients for whom a drug may pose a significant risk of harm. Knowing ... are not appropriate candidates for a certain drug may help increase the likelihood that a product ...

Quark Pharmaceuticals to Participate in IBC's Oligonucleotide Therapeutics: From Concept to Implementation Conference

... August 3-5, 2009 in Boston, MA as part of IBC's drug Discovery Week. Dr. Thompson has been appointed a ... therapeutics. Quark has a fully integrated drug development platform that spans therapeutic target identification to drug development. Quark's RNAi technology includes ...

Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)

... DosePro technology is an easy-to-use, pre-filled drug delivery system designed to enable self-administration of single doses of liquid drug formulations, subcutaneously, without a needle. ... healthy volunteers using the DosePro needle-free drug delivery system. About Zogenix ...

Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms

... cause a decline of more than eight percent in the drug market for benign prostatic hyperplasia and male ... since 2006 and, in the first half of 2010, the drug will be generically available in the United ... the primary concern in treating the disease, drug development for benign prostatic hyperplasia has ...